Table 1.
Baseline Characteristics
| Characteristics | |
|---|---|
| Median (range) Age, y | 60 (19–92) |
| Men, No. (%) | 132 (54) |
| Ann Arbor Stage, No. (%) | |
| I | 50 (20.4) |
| II | 46 (18.8) |
| III | 28 (11.4) |
| IV | 121 (49.4) |
| LDH, No. (%) | |
| >Normal | 114 (46.5) |
| ≤Normal | 131 (53.5) |
| Extranodal Sites of Disease, No. (%) | |
| >1 | 73 (29.8) |
| ≤1 | 172 (70.2) |
| ECOG PS, No. (%) | |
| >1 | 12 (4.9) |
| ≤1 | 233 (95.1) |
| IPI, No. (%) | |
| 0–1 | 100 (41.0) |
| 2 | 66 (27.0) |
| 3 | 57 (23.4) |
| 4 | 21 (8.6) |
| Radiation Treatment, No. (%) | 63 (26.7) |
| Absolute Monocyte Count, Median (IQR) | 500/µL (60–1710/µL) |
| Absolute Lymphocyte Count, Median (IQR) | 1330/µL (0–1178/µL) |
Abbreviations: ECOG PS = Eastern Cooperative Oncology Group Performance Status; IPI = international prognostic index; IQR = interquartile range; LDH = lactic dehydrogenase.